Advertisement

Drugs

, Volume 45, Supplement 3, pp 399–400 | Cite as

Ofloxacin and Erythromycin in the Management of Diffuse Panbronchiolitis

  • Atsuhiko Sato
  • Hiroshi Hayakawa
  • Takafumi Suda
Poster Presentations Respiratory Tract Infections — Bronchitis

Keywords

Erythromycin Ofloxacin Acute Exacerbation Haemophilus Influenzae Romycin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Homma H, Yamanaka A, Tanimoto S, Tamura M, Chijimatsu Y, et al. Diffuse panbronchiolitis. A disease entity of the transitional zone of the lung. Chest 83: 63, 1983Google Scholar
  2. Sato A, Hayakawa H, Okano A. Pathology and treatment of diffuse panbronchiolitis (DPB) accompanied by hyperplasia in bronchus-associated lymphoid tissue (BALT). Japanese Journal of Medicine 25: 391, 1986Google Scholar
  3. Yamamoto M, Kondo A, Tamura M, Izumi T, Ina Y, et al. Longterm therapeutic effects of erythromycin and new quinolone antibacterial agents on diffuse panbronchiolitis. Japanese Journal of Thoracic Diseases 28: 1305–1313, 1990PubMedGoogle Scholar

Copyright information

© ADIS International Limited 1993

Authors and Affiliations

  • Atsuhiko Sato
    • 1
  • Hiroshi Hayakawa
    • 1
  • Takafumi Suda
    • 1
  1. 1.Second Department of Internal MedicineHamamatsu University School of MedicineHamamatsu 431-31, ShizuokaJapan

Personalised recommendations